IP Library Granted Patent US 8,299,124
Granted Patent B2
US 8,299,124 · App. 13/332,827 · Granted Oct 30, 2012

Aqueous intraocular penetration-promoting eye drop

Assignee: Senju Pharmaceutical Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,299,124
App. No.
13/332,827
Granted
Oct 30, 2012
Kind
B2
Abstract

An aqueous eye drop comprising 2-amino-3-(4-bromobenzoyl)phenylacetic acid or its pharmacologically acceptable salt or a hydrate thereof and an organic amine (for example, aminoethylsulfonic acid or trometamol) or a salt thereof is useful as an eye drop for once a day administration for treating inflammatory diseases of the external segment or the anterior segment of the eyes, since such aqueous eye drop can maintain a therapeutically effective concentration of 2-amino-3-(4-bromobenzoyl)phenylacetic acid in anterior aqueous humor for at least 24 hours by once a day administration.

Claims (4)

1. A method for promoting intraocular penetration of 2-amino-3-(4-bromobenzoyl)phenylacetic acid or its pharmacologically acceptable salt or a hydrate thereof, which comprises administering an aqueous eye drop comprising 2-amino-3-(4-bromobenzoyl)phenylacetic acid or its pharmacologically acceptable salt or a hydrate thereof and an organic amine selected from the group consisting of aminoethylsulfonic acid and aminomethylsulfonic acid or a salt thereof, wherein the content of the organic amine or salt thereof is an amount to allow the octanol-water partition coefficient of 2-amino-3-(4-bromobenzoyl)phenylacetic acid to be 0.7 to 4.

2. The method according to claim 1 , wherein the concentration of 2-amino-3-(4-bromobenzoyl)phenylacetic acid or its pharmacologically acceptable salt or a hydrate thereof in the aqueous eye drop is 0.01 to 0.5w/v %.

3. The method according to claim 1 , wherein the organic amine or salt thereof has a concentration of 0.05 to 5w/v %.

4. The method according to claim 1 , wherein the organic amine is aminoethylsulfonic acid.

Assignments (1)
CHANGE OF ADDRESS Recorded Aug 24, 2018
From: SENJU PHARMACEUTICAL CO., LTD.
To: SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 046835/0350 →
Priority Claims (1)
JP 2004-322569 · Nov 5, 2004 · national
Continuity (2)
Division 10568418
Related Publication 20120095101A1 · Apr 19, 2012